US Patent Issued to The Johns Hopkins University, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES on Jan. 20 for "Peptide hydrogels for delivery of immunosuppressive drugs and uses thereof" (Maryland Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,870, issued on Jan. 20, was assigned to The Johns Hopkins University (Baltimore) and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Bethesda, Md.).

"Peptide hydrogels for delivery of immunosuppressive drugs and uses thereof" was invented by Joel P. Schneider (Frederick, Md.), Poulami Majumder (Frederick, Md.) and Giorgio Raimondi (Severna Park, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions that include a cationic peptide hydrogel and an immunosuppressive small molecule drug are described. The small molecule drug is crystallized and dispersed in the peptide hydrogel to allow f...